Cargando…

Cardiac Energy Dependence on Glucose Increases Metabolites Related to Glutathione and Activates Metabolic Genes Controlled by Mechanistic Target of Rapamycin

BACKGROUND: Long chain acyl‐CoA synthetases (ACSL) catalyze long‐chain fatty acids (FA) conversion to acyl‐CoAs. Temporal ACSL1 inactivation in mouse hearts (Acsl1(H−/−)) impaired FA oxidation and dramatically increased glucose uptake, glucose oxidation, and mTOR activation, resulting in cardiac hyp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schisler, Jonathan C., Grevengoed, Trisha J., Pascual, Florencia, Cooper, Daniel E., Ellis, Jessica M., Paul, David S., Willis, Monte S., Patterson, Cam, Jia, Wei, Coleman, Rosalind A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345858/ https://www.ncbi.nlm.nih.gov/pubmed/25713290 http://dx.doi.org/10.1161/JAHA.114.001136

Ejemplares similares

Modeling the Transition From Decompensated to Pathological Hypertrophy
por: Pascual, Florencia, et al.
Publicado: (2018)

Compartmentalized Acyl-CoA Metabolism in Skeletal Muscle Regulates Systemic Glucose Homeostasis
por: Li, Lei O., et al.
Publicado: (2015)

Rapamycin regulates biochemical metabolites
por: Tucci, Paola, et al.
Publicado: (2013)

Mechanistic Target of Rapamycin Pathway in Epileptic Disorders
por: Kim, Jang Keun, et al.
Publicado: (2019)

mTORtuous effect on the elastic heart
por: Schisler, Jonathan C., et al.
Publicado: (2015)

Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
por: Murray, James T., et al.
Publicado: (2018)

Emerging evidence of coding mutations in the ubiquitin–proteasome system associated with cerebellar ataxias
por: Ronnebaum, Sarah M, et al.
Publicado: (2014)

Mechanism of Activation of Mechanistic Target of Rapamycin Complex 1 by Methionine
por: Kitada, Munehiro, et al.
Publicado: (2020)

Mechanistic target of rapamycin inhibitors: successes and challenges as cancer therapeutics
por: Bhaoighill, Muireann Ní, et al.
Publicado: (2019)

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
por: Querfurth, Henry, et al.
Publicado: (2021)

Muscle ring finger-3 protects against diabetic cardiomyopathy induced by a high fat diet
por: Quintana, Megan T., et al.
Publicado: (2015)

Adverse Effects of Fenofibrate in Mice Deficient in the Protein Quality Control Regulator, CHIP
por: Ravi, Saranya, et al.
Publicado: (2018)

The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment
por: Maiese, Kenneth
Publicado: (2020)

Mechanistic target of rapamycin signaling in human nervous system development and disease
por: Girodengo, Marie, et al.
Publicado: (2022)

Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system
por: Arriola Apelo, Sebastian I., et al.
Publicado: (2015)

Mechanistic Target of Rapamycin (Mtor) Is Essential for Murine Embryonic Heart Development and Growth
por: Zhu, Yi, et al.
Publicado: (2013)

The Role of Mechanistic Target of Rapamycin (mTOR) Complexes Signaling in the Immune Responses
por: Soliman, Ghada A.
Publicado: (2013)

mTOR Mysteries: Nuances and Questions About the Mechanistic Target of Rapamycin in Neurodegeneration
por: Norwitz, Nicholas G., et al.
Publicado: (2020)

Haploinsufficiency of mechanistic target of rapamycin ameliorates bag3 cardiomyopathy in adult zebrafish
por: Ding, Yonghe, et al.
Publicado: (2019)

Mechanistic target of rapamycin kinase (Mtor) is required for spermatogonial proliferation and differentiation in mice
por: Cao, Jun, et al.
Publicado: (2019)

Mechanistic Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Potential, Limitations, and Perspectives
por: Faes, Seraina, et al.
Publicado: (2021)

Amino acids and mechanistic target of rapamycin regulate the fate of live engulfed cells
por: Kim, Sung Eun, et al.
Publicado: (2021)

Genetic and Environmental Contributions to Autism Spectrum Disorder Through Mechanistic Target of Rapamycin
por: Sato, Atsushi, et al.
Publicado: (2021)

Enhanced activation of mechanistic target of rapamycin complex 1 signaling in eruptive xanthomas
por: Huang, Yan, et al.
Publicado: (2023)

Rapamycin inhibits spermatogenesis by changing the autophagy status through suppressing mechanistic target of rapamycin-p70S6 kinase in male rats
por: Liu, Shangjing, et al.
Publicado: (2017)

Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway
por: Iida, Keitaro, et al.
Publicado: (2020)

Mechanistic Target of Rapamycin Complex 2 Regulation of the Primary Human Trophoblast Cell Transcriptome
por: Rosario, Fredrick J., et al.
Publicado: (2021)

COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition
por: Baldi, Bruno Guedes, et al.
Publicado: (2022)

Mechanistic/mammalian target of rapamycin and side effects of antipsychotics: insights into mechanisms and implications for therapy
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Involvement of Mechanistic Target of Rapamycin (mTOR) in Valine Orexigenic Effects in Rainbow Trout
por: Comesaña, Sara, et al.
Publicado: (2022)

MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet
por: He, Jun, et al.
Publicado: (2015)

Pharmacokinetics of Glutathione and Its Metabolites in Normal Subjects
por: Hong, Sae-Yong, et al.
Publicado: (2005)

Fasting and rapamycin: diabetes versus benevolent glucose intolerance
por: Blagosklonny, Mikhail V.
Publicado: (2019)

Depletion of PHD3 Protects Heart from Ischemia/Reperfusion Injury by Inhibiting Cardiomyocyte Apoptosis
por: Xie, Liang, et al.
Publicado: (2015)

Immunohistochemical Analysis of the Mechanistic Target of Rapamycin and Hypoxia Signalling Pathways in Basal Cell Carcinoma and Trichoepithelioma
por: Brinkhuizen, Tjinta, et al.
Publicado: (2014)

Insulinoma and Tuberous Sclerosis: A Possible Mechanistic Target of Rapamycin (mTOR) Pathway Abnormality?
por: Kang, Michael Yoon, et al.
Publicado: (2017)

Mechanistic target of rapamycin is necessary for changes in dendritic spine morphology associated with long-term potentiation
por: Henry, Fredrick E., et al.
Publicado: (2017)

Effect of mechanistic target of rapamycin inhibitors on postrenal transplantation malignancy: A nationwide cohort study
por: Hou, Yi‐Chou, et al.
Publicado: (2018)

Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex
por: Lu, Yiyang, et al.
Publicado: (2020)

Reactivation of cocaine contextual memory engages mechanistic target of rapamycin/S6 kinase 1 signaling
por: Shi, Xiangdang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_snun9bub0dmibtp56ii939gd8g